Clinical Trial

The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials

Recruiting
View on ClinicalTrials.gov →
Summary
The purpose of this study is to conduct a Hybrid Type 1 cluster-randomized, roll-out effectiveness-implementation trial in NCORP community oncology practice sites (N= 500 Black and Latino cancer patients) to evaluate the effectiveness of the EA SUPPORT intervention combining CT navigators and CT research literacy tools in improving Black and Latino patient referral and accrual to NCI-supported CTs (primary outcomes) and participant and provider awareness and knowledge of CTs (secondary outcomes) while assessing implementation factors. Also, with the CUSP2CT data, Evaluation, and Coordinating Center, conduct final site evaluation and disseminate the SUPPORT intervention to NCORP community oncology sites, research bases, and affiliated trial networks.
Protocol Amendment History 2 changes
notable Primary completion moved earlier: 2028-08-01 -> 2027-08-01 2026-07-22
minor Completion moved earlier: 2029-08-01 -> 2028-03-01 2026-07-22
Trial Details
NCT Number NCT06756607
Lead Sponsor Eastern Cooperative Oncology Group
Conditions Cancer
Enrollment 500 participants
Start Date 2025-04-25
Primary Completion 2027-08-01 (estimated)
Study Completion 2028-03-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-21